Avidity Partners Management LP Immunic, Inc. Transaction History
Avidity Partners Management LP
- $370 Million
- Q2 2025
A detailed history of Avidity Partners Management LP transactions in Immunic, Inc. stock. As of the latest transaction made, Avidity Partners Management LP holds 5,615,811 shares of IMUX stock, worth $4.77 Million. This represents 1.06% of its overall portfolio holdings.
Number of Shares
5,615,811
Previous 4,454,408
26.07%
Holding current value
$4.77 Million
Previous $4.86 Million
19.03%
% of portfolio
1.06%
Previous 1.09%
Shares
5 transactions
Others Institutions Holding IMUX
# of Institutions
61Shares Held
50MCall Options Held
13.2KPut Options Held
60.6K-
Abrdn PLC8.24MShares$7.01 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA7.65MShares$6.51 Million0.21% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$6.2 Million0.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.13MShares$3.51 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.63MShares$3.08 Million0.0% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $26M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...